Etodolac

Etodolac

• Long experience in in-house commercial manufacturing
• Wide regulatory documentation

Status	Commercial
Therapeutic cat.	Musculo-skeletal
Polymorphic form	Crystalline racemate, none
CAS No.	41340-25-4
EU DMF readiness
CEP
JAPANESE DMF
KOREAN  DMF
CANADIAN  DMF
CADIFA
US DMF readiness

Drug description

Etodolac is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing hormones that cause inflammation and pain in the body. Etodolac is used to treat mild to moderate pain, osteoarthritis, or rheumatoid arthritis. Etodolac may also be used for purposes not listed in this medication guide.

Disclaimer: Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).